Shingrix vial kits
Ended Awarded Last action
- Contract number
- SPE2DR26FNR2E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,103
Award facts
- Contract value 100% obligated
- $1,102.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,102.87 by the Defense Logistics Agency (DLA) on January 8, 2026, for Shingrix vial kits with an ultimate completion date of January 9, 2026. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026, which enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which serves as the parent organization and holds the primary IDC with DLA valued at up to $999,999,999.00 through December 31, 2031. The Shingrix order supports the Defense Health Agency and broader military medical supply chain requirements. Shingrix, a recombinant zoster vaccine, is a critical immunization product for protecting eligible populations against herpes zoster, reflecting the DLA's ongoing commitment to maintaining essential pharmaceutical inventories for military healthcare systems and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FNR2E?
SPE2DR26FNR2E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FNR2E worth?
The government has obligated $1,103 on SPE2DR26FNR2E.
Is contract SPE2DR26FNR2E an order under another contract?
Yes. SPE2DR26FNR2E is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNR2E competed?
The extent of competition for SPE2DR26FNR2E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award